期刊文献+

他汀类药物的抗心律失常作用

Anti-arrhythmia effect of statins
下载PDF
导出
摘要 随着临床药理学的研究进展,发现许多非抗心律失常药物具有抗心律失常的作用,且已被临床实践所证实.以往曾有许多非抗心律失常药物用于心律失常的治疗,如硫酸镁治疗房扑、房颤、室上速、室速等,辅酶Q10用于房早、室早,ATP用于阵发性室上速,烟酰胺用于病窦、房室传导阻滞,小檗碱用于房早、室早、室上速等.
作者 赵秀丽 武峰
出处 《临床药物治疗杂志》 2005年第4期29-31,共3页 Clinical Medication Journal
  • 相关文献

参考文献14

  • 1[1]Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C - reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation,2001,103 (9): 1191 ~ 1193
  • 2[2]Nissen SE,Tuzcu EM,Schoenhagen P,et al. Statin therapy,LDL cholesterol, C - reactive protein, and coronary artery disease. N Engl J Med,2005 Jan 6,352( 1 ) :29 ~38
  • 3冯胜民,史美甫.他汀类药物非降脂作用临床研究进展[J].中国药业,2001,10(12):1-3. 被引量:2
  • 4[4]Diomede L, Albani D, Sottocorno M, et al. In Vivo Antiinflammatory Effect of Statins is Mediated by Nonsterol Mevalonate Products. Arteriscler Thromb Vase Biol,2001,21:1327 ~ 1332
  • 5[5]Aviram M, Hussein O, Mira R. Interaction of platelets, macrophage and lipoproteins in hypercholesterolemia:Antiatherogenic effects of HMG - CoA reductase inhibitor therapy. J Cardiavasc Pharmacol, 1998,31: 39 ~ 45
  • 6[6]Shunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, et al. Fluvastatin,a 3 - Hydroxy - 3 - Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction. Circulation,2002,105: 868 ~ 873
  • 7[7]Takemoto M,Grimm M, Takemoto Y, et al. HMG - CoA reductase inhibitors attenuate angiotensin - Ⅱ induced cardiac hypertrophy. Circulation, 2000,102 ( suppl. 2 ): S133
  • 8[8]Schwartz G G, Olsson A G, Ezekowitz M D, et al. Effect of atorvastatin on early recurrent ischemia events in acute coronary syndrome, The MIRACL Study, A randomized clinical trial. JAMA,2001,285 ( 3 ): 1771 ~ 1778
  • 9曾群英,高修仁,许庆,王强,郑东诞,陶军,廖新学,陈国伟.急性冠状动脉综合征早期应用阿托伐他汀治疗的作用和安全性的临床研究[J].中西医结合心脑血管病杂志,2004,2(4):234-237. 被引量:2
  • 10陈定,孔繁荣,赵坚.辛伐他汀对老年冠心病患者QT离散度的影响[J].实用老年医学,2000,14(3):163-164. 被引量:2

二级参考文献31

  • 1Keogh A,Macdonald P,Kan A,et al. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation[J]. J Heart- Lung Transplant, 2000,19(6) :529 - 537.
  • 2Wanner C, Quaschning T, Weingarntern K. Impact of dyslipidaemia in renal transplant recipients[J]. Curr Opin Urol,2000,10(2):77-80.
  • 3Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethyl glutaryl- coenzyme A reductase and risk of fracture among older women[J]. Lancet,2000,355:2 185 - 2 188.
  • 4Wang PS, Solomon DH, Mogun H,et al. HMG- CoA reductase inhibitor and the risk of hip fracture in elder patients[J]. JAMA,2000,283(24):3211 -3216.
  • 5Sugiyama M,Kodama T,Lonishi K,et al. Compactin and simvastatin,but not pravastatin ,induce bone myophogenetic protein- 2 in human osteosarcoma cell[J]. Biochem Biophys Res Commun,2000,271 (3):688 - 692.
  • 6Jick H,Zornberg GL,Jick SS,et al. Statin and the risk of dementia[J].Lancet, 2000,356:1 627 - 1 631.
  • 7Wolozin B, Keuman W, Roussean P, et al. Decreased prevalence of Alzheimer' s disease associated with 3- hydroxy- 3- menthy-lglutaryl coenzyme A reductase inhibitors[J]. Arch Neurol,2000,57:1439 - 1443.
  • 8Oda H, Heane WF. Recent advance in statins and the kidney[J].idney Int, 1999, 56 (supp31 ): s2 - 5.
  • 9Aviram M, Hussein O, Mira R. Interaction of platelets, macrophage and lipoproteins in hypercholesterolemia: Antiatherogenic effects of HMGCoA reductase inhibitor therapy [ J ]. J Cardiavasc Pharmacol, 1998,31:39 - 45.
  • 10Barrow N,Stratton PD,Benjiamin N. Reduction of LDL cholesterol by pravastatin does not influence platelet action in patient with mild hyercholesterolaemia at risk of coronary heart disease[J]. Br J ClinPharmacol, 1991,32:127 - 129.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部